Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Matei

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2025
Reply to: Comment on The Study of NRG258: Limitations and Future DirectionsDaniela Matei
Expert Opinion on Investigational Drugs|August 10, 2007
Novel agents in ovarian cancerDaniela Matei
The Lancet. Oncology|June 18, 2021
Immunotherapy in ovarian cancer: we are not there yetEmma Barber, Daniela Matei
Cancer Biology & Therapy|August 6, 2010
Blockade of FGF signaling: therapeutic promise for ovarian cancerMircea Ivan, Daniela Matei
Therapeutics and Clinical Risk Management|August 27, 2009
Pegylated liposomal doxorubicin in ovarian cancerRobert Strother, Daniela Matei
Cancer Treatment Reviews|July 19, 2011
Targeting angiogenesis in ovarian cancerJordan Schmitt, Daniela Matei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to InclusionDario R Roque, Daniela Matei
Cancer Research|May 9, 2020
Epigenetic Attire in Ovarian Cancer: The Emperor's New ClothesDaniela Matei, Kenneth P Nephew
The Journal of Reproductive Medicine|August 4, 2010
Breast mass in a patient with ovarian cancer: a case reportSuresh Gayathri, Sunil Badve, Daniela Matei
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 4, 2013
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanismSalvatore Condello, Liyun Cao, Daniela Matei
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2025
Reply to: Comment on The Study of NRG258: Limitations and Future DirectionsDaniela Matei
Expert Opinion on Investigational Drugs|August 10, 2007
Novel agents in ovarian cancerDaniela Matei
The Lancet. Oncology|June 18, 2021
Immunotherapy in ovarian cancer: we are not there yetEmma Barber, Daniela Matei
Cancer Biology & Therapy|August 6, 2010
Blockade of FGF signaling: therapeutic promise for ovarian cancerMircea Ivan, Daniela Matei
Therapeutics and Clinical Risk Management|August 27, 2009
Pegylated liposomal doxorubicin in ovarian cancerRobert Strother, Daniela Matei
Cancer Treatment Reviews|July 19, 2011
Targeting angiogenesis in ovarian cancerJordan Schmitt, Daniela Matei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to InclusionDario R Roque, Daniela Matei
Cancer Research|May 9, 2020
Epigenetic Attire in Ovarian Cancer: The Emperor's New ClothesDaniela Matei, Kenneth P Nephew
The Journal of Reproductive Medicine|August 4, 2010
Breast mass in a patient with ovarian cancer: a case reportSuresh Gayathri, Sunil Badve, Daniela Matei
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 4, 2013
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanismSalvatore Condello, Liyun Cao, Daniela Matei
Pageof 19